ArticleACS omega2024

Preclinical Evaluation of JAB-2485, a Potent AURKA Inhibitor with High Selectivity and Favorable Pharmacokinetic Properties.

Guiqun Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.